Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma have?
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma has 859 citations in the OpenAlex counts ScholarIQ stores.
When was Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma published?
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma has 2023 year in the ScholarIQ index.
What is the open-access status of Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma?
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma has green oa status in the ScholarIQ index.
What is the DOI of Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma?
The DOI for Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma is on the source record.
What is the PMID of Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma?
The PMID for Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma is on the source record.
What is the OpenAlex record for Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma?
The OpenAlex for Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma is on the source record.